CEO: Jean-Jacques Bienaime

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions.


Key numbers

Market Capitalization:13479060000
Shares Outstanding: 179625000
Float: 178249431.75
Next Earning Date:2020-02-24
TTm EPS: -0.2394
TTm Dividend Rate:
200 days moving average:81.56
50 days moving average: 71.17
One day percent Change: 3.18



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,